The Patent Finder

DRG International, Inc.

Also on record
Records under this name other than patents DRG International, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 10 of 10 · Back to DRG International, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,017,737Diagnostic methods for diseases by screening for hepcidin in human or animal tissues, blood or body fluids; monoclonal antibodies specific to human hepcidin and associated uses therefor
Term ended
Term ended Jul 14, 2024 · USPTO record
Term endedTerm ended Jul 14, 2024USPTO record
US 7,411,048Diagnostic method for diseases by screening for hepcidin in human or animal tissues, blood or body fluids
Term ended
Term ended May 27, 2024 · USPTO record
Term endedTerm ended May 27, 2024USPTO record
US 7,320,894Diagnostic method for diseases by screening for hepcidin in human or animal tissues, blood or body fluids and therapeutic uses therefor
Term ended
Term ended Apr 14, 2024 · USPTO record
Term endedTerm ended Apr 14, 2024USPTO record
US 7,749,713Diagnostic method for diseases by screening for hepcidin in human or animal tissues, blood or body fluids and therapeutic uses therefor
Term ended
Term ended Apr 13, 2024 · USPTO record
Term endedTerm ended Apr 13, 2024USPTO record
US 7,649,081Diagnostic method for diseases by screening for hepcidin in human or animal tissues, blood or body fluids and therapeutic uses therefor
Term ended
Ended no later than Nov 19, 2022 · USPTO record
Term endedEnded no later than Nov 19, 2022USPTO record
US 7,998,691Diagnostic method for diseases by screening for hepcidin in human or animal tissues, blood or body fluids and therapeutic uses therefor
Term ended
Term ended Nov 19, 2022 · USPTO record
Term endedTerm ended Nov 19, 2022USPTO record
US 8,003,338Diagnostic method for diseases by screening for hepcidin in human or animal tissues, blood or body fluids and therapeutic uses therefor
Term ended
Term ended Nov 19, 2022 · USPTO record
Term endedTerm ended Nov 19, 2022USPTO record
US 8,263,352Diagnostic method for diseases by screening for hepcidin in human or animal tissues, blood or body fluids and therapeutic uses therefor
Term ended
Ended no later than Nov 19, 2022 · USPTO record
Term endedEnded no later than Nov 19, 2022USPTO record
US 8,304,197Diagnostic method for diseases by screening for hepcidin in human or animal tissues, blood or body fluids and therapeutic uses therefor
Term ended
Ended no later than Nov 19, 2022 · USPTO record
Term endedEnded no later than Nov 19, 2022USPTO record
US 8,304,258Methods of producing monoclonal antibodies specific for human hepcidin
Term ended
Term ended Nov 19, 2022 · USPTO record
Term endedTerm ended Nov 19, 2022USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited